<code id='9F8193D64B'></code><style id='9F8193D64B'></style>

<acronym id='9F8193D64B'></acronym>

<center id='9F8193D64B'><center id='9F8193D64B'><tfoot id='9F8193D64B'></tfoot></center><abbr id='9F8193D64B'><dir id='9F8193D64B'><tfoot id='9F8193D64B'></tfoot><noframes id='9F8193D64B'>

<optgroup id='9F8193D64B'><strike id='9F8193D64B'><sup id='9F8193D64B'></sup></strike><code id='9F8193D64B'></code></optgroup>

<b id='9F8193D64B'><label id='9F8193D64B'><select id='9F8193D64B'><dt id='9F8193D64B'><span id='9F8193D64B'></span></dt></select></label></b><u id='9F8193D64B'></u>

~~<i id='9F8193D64B'><strike id='9F8193D64B'><tt id='9F8193D64B'><pre id='9F8193D64B'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

leisure time

author：fashion 2025-09-29 11:32:43 Page View：55

UnitedHealth Group — UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

advertisement

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Intermittent fasting comes with a heart risk? Not so fast
Next article： Medicare proposal to cover medical devices draws a mixed reaction

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

A Q&A with the global head of Boehringer Ingelheim's innovation unit

A Q&A with the global head of Boehringer Ingelheim's innovation unit

MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr

Tori Bowie and the unacceptable rates of Black maternal death

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

FDA panel signals lack of confidence in Amgen cancer drug data

AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru

read more